美國

證券交易委員會

華盛頓特區20549

表格 8-K

目前的報告

根據第13或15(d)條款

證券交易法（1934年）第13條或第15(d)條規定

報告日期（最早報告事項日期）：2024年10月30日

大西洋沿岸收購公司II

(根據其章程規定的註冊人準確名稱)

(248) 890-7200

(註冊人電話號碼，包括區號)

無數據

(如果自上次報告以來發生更改，請填寫前名稱或前地址。)

如果所提交的表格申報旨在同時滿足註冊人在以下規定項下的任何一項申報義務，請選中以下適當的框（見下面的A.2指導方針）：8-K 本報告旨在同時滿足申報人根據以下任何規定的申報義務（請參見下面的一般指示A.2）：

根據法案第12（b）條註冊的證券:

請在檢查標記處打勾，表示註冊公司是否符合1933年證券法規定的新興成長型公司(本章第230.405條)或1934年證券交易法規定的第120億.2條(本章第2401.2億.2條)。

新興成長企業☒

如果是新興成長型企業，請勾選，表明註冊者已選擇不使用根據證券交易所法第13(a)條規定提供的任何新的或修訂的財務會計準則的延長過渡期。☐

如前披露，大西洋沿岸收購公司II，一家特拉華州公司（「我們」，「ACAB」或「公司」）已就擬議的業務組合（「業務組合」）與Abpro公司（特拉華州公司）（「Abpro」）達成協議。

如前披露，於2024年10月18日，公司的Form表格Registraton Statement生效，公司提交了與業務組合相關的代理人聲明書/招股書（「代理人聲明書/招股書」）。 S-4 展開完整的內容，以免丟失。蘋果CEO庫克大規模出售股票，套現逾3億港元。

約克維爾協議

於2024年10月30日，公司和Abpro與YA II PN有限公司（「投資者」）簽署了備用股權購買協議（「SEPA」）。在此未定義並使用的大寫字母術語應具有SEPA中規定的含義，該SEPA作爲表格10.1附在本次報告中，且以引用方式納入本文。 8-K 如前披露，於2024年10月18日，公司的Form表格Registraton Statement生效，公司提交了與業務組合相關的代理人聲明書/招股書（「代理人聲明書/招股書」）。

預付 愛文思控股

在SEPA規定的條件滿足的前提下，投資者應向公司提前支付500萬美元的總本金金額（該 預付款 預付款），其中將以可轉換的本票作爲憑證（每一張「本票」），其格式附在本《當前表格上 8-K 作爲附件10.3展示，並通過參考併入本文。第一 預付 預付款應爲300萬美元的本金金額，並在業務合併結束後的第一個交易日提前支付，第二 預付 愛文思控股應以2,000,000美元的本金金額提前支付，最晚爲（i）根據註冊權協議（如下定義）提交的首次註冊聲明生效後的第二個交易日和（ii）取得超出交易所限額髮行公司普通股所需股東批准後的第二個交易日。每次 預先準備 在每次結束時，投資者應向公司提前支付本金金額，減去折扣金額，該折扣金額等於提前支付的本金金額的8％，從應付購買價格淨額中抵消，並以立即可用的資金支付到公司書面指定的帳戶，公司應交付一張本票，本票本金金額等於該金額的全額 預付 提前支付，減去折扣金額，該折扣金額等於提前支付的本金金額的8％，從應付購買價格淨額中抵消，並以立即可用的資金支付到公司書面指定的帳戶，公司應交付一張本票，本票本金金額等於該金額的全額 預付 提前支付，減去折扣金額，該折扣金額等於提前支付的本金金額的8％，從應付購買價格淨額中抵消，並以立即可用的資金支付到公司書面指定的帳戶，公司應交付一張本票，本票本金金額等於該金額的全額 預付 公司代表已經進行了適當的愛文思控股。

8,674,018

在業務組合結束時，公司有權但無義務根據SEPA向投資者發行其普通股的股份（「預付股份」，及此類發行和出售，稱爲「預付款」），投資者應通過公司發給投資者的書面通知（「預付通知」）認購及購買公司發行的預付股份，前提是（i）在匹配票據下沒有未結餘額，或者（ii）在匹配票據下有未結餘額時，按照SEPA的條款和條件發生了分期償還事件（在匹配票據中定義），公司有選擇權選擇希望在每次預付通知中向投資者發行並出售的預付股份數量不超過最高預付款金額（以下定義）的規定。如果任何匹配票據下仍有未結餘額，未經投資者事先書面同意，公司只能（除按照下文所述的投資者通知進行的視爲預付通知的情況外）提交預付通知（A）如果發生了分期償還事件，公司根據匹配票據的規定仍有義務按月償還預付款且（B）投資者通過償還公司的從此類預付款中獲得的款項抵消未結餘額的相等金額從而支付公司應付的總購買價格，視情況符合SEPA的條款和條件。

只要匹配票據中仍有未結餘額，投資者有權但無義務通過向公司提交投資者通知（根據SEPA中定義的通知）的方式致使被視爲送達給投資者的預付通知，從而觸發向投資者發行和出售預付股份的情況，具體條款和條件如SEPA所示。

「最高預付金額」指（A）公司根據SEPA適用條款發出的每份預付通知，其金額等於該預付通知前五個連續交易日其普通股每日交易量的百分之一百（100%）；以及（B）公司根據投資者通知視爲發出的每份預付通知，投資者在該投資者通知中選定的金額，該金額不得超過SEPA第3.02節規定的限制，其中包括：（i）投資者及其關聯方所持有的公司普通股股份不得超過公司當時流通投票權或普通股股份總數的百分之四點九九（4.99%）；（ii）公司根據SEPA向投資者發行及出售的股份數量不得超過SEPA項下交易的註冊聲明（如下所定義）生效的特定日期註冊的金額；以及（iii）根據預付款預先支付款額髮行的普通股數量（其中包括在其他預付款項下發行的普通股）不得超過SEPA生效日期時公司已發行的普通股總數的百分之十九點九（19.9%）（「交易上限」）。如果：（a）公司股東依照納斯達克證券交易所適用規則批准發行超出交易上限的普通股；或（b）根據SEPA發行的全部普通股的平均售價等於或高於以下兩者中的較低者（i）SEPA生效日期之前納斯達克官方收盤價；或（ii）SEPA生效日期前五個交易日的納斯達克官方收盤價。SEPA擬定投資者購買公司新發行普通股的總購買價格高達5000萬美元。

Advance Shares的購買價格應爲通過將市場價格（i）乘以96%得到的每股Advance Share價格，針對由公司提交具有Option 1定價期限的Advance Notice（此期限以紐約時間上午9:00提交Advance Notice並參考VWAP的交易日開始計算，或者在紐約時間上午9:00後提交時，以投資者確認收到時爲準），價格爲96%；針對具有Option 2定價期限的Advance Notice，價格爲97%（此期限根據Advance Notice日期起計的連續三個交易日的最低日常VWAP確定）；或（iii）針對根據投資者通知提交的任何Advance Notice，價格等於轉股價格（定義在本票據中）。

登記權協議

公司、Abpro和投資者還簽署了一份註冊權協議（「註冊權協議」），日期爲2024年10月30日，根據該協議，公司同意向證券交易委員會提交一份註冊聲明，覆蓋註冊權協議項下的可登記證券的轉售，包括公司根據SEPA向投資者發行的普通股。SEPA、註冊權協議、本票據以及與之相關的文件，共稱爲「融資協議」 。

對於融資協議的上述描述並不完整，完整內容請參閱附在本次有關最新報告的附件10.1、10.2和10.3的SEPA、註冊權協議和本票據形式的全文，各項均已併入本報告。 8-K ，分別作爲本報告的展示文件10.1、10.2和10.3附載，均已併入本報告。

在本次形式的現行報告中，Item 1.01中所列信息 8-K 已在此引用本次關於Form的當前報告項下的9.01項下披露的信息。

在本次形式的現行報告中，Item 1.01中所列信息 8-K 已在此引用本次關於Form的當前報告項下的9.01項下披露的信息。

在SEPA中，投資者對公司做出了諸多承諾，其中包括其是「認定投資者」（如《證券法》下501(a)規則》D條款下定義的那樣）。本《當前報告表格》中涉及的證券。 8-K 根據證券法第4(a)(2)條的豁免規定，公司向投資者發行並銷售證券。

代理人聲明書/招股說明書補充

這些補充信息應與代理人聲明書/招股說明書一併閱讀。下述披露中的頁面參考指的是代理人聲明書/招股說明書中的頁面，未在這裏定義但在代理人聲明書/招股說明書中定義的術語具有該聲明書/招股說明書中規定的含義。在下述信息與代理人聲明書/招股說明書中的信息有任何不同或衝突的情況下，以下信息應被視爲替代代理人聲明書/招股說明書中相應信息。並沒有以任何方式承認以下披露具有重要性或法律要求性，ACAb提出以下修訂和補充披露。

The following disclosure on page 37 is amended and restated as follows (new text in underline):

…Pursuant to the Subscription Agreements, ACAB agreed that, within 30 calendar days after the consummation of the Business Combination, ACAB will file with the SEC a registration statement registering the resale of the Subscriber Committed Shares (the “PIPE Resale Registration Statement”), and ACAB will use its commercially reasonable efforts to have the PIPE Resale Registration Statement declared effective as soon as practicable after the filing thereof.

Yorkville Financing

On October 30, 2024, Abpro, ACAB and YA II PN, Ltd (“Yorkville”) entered into a Standby Equity Purchase Agreement (the “SEPA”). Under the SEPA, Yorkville would advance $3 million to the Post-Combination Company following the closing of the Business Combination, and an additional $2 million upon the later of (a) the effectiveness of a resale registration statement covering the sale of shares received by Yorkville under the SEPA and (b) shareholder approval of the issuance of shares to Yorkville under the SEPA, in exchange for a promissory note in connection with such advances (the “Yorkville Note”). Each advance would be made at an 8% original issue discount. The Yorkville Note is due and payable in cash after 12 months (subject to acceleration by amortization events specified in the Yorkville Note), or, at the election of Yorkville, at any time in whole or in part in shares at a price per share calculated in accordance with the Yorkville Note. The Yorkville Note may be redeemed by the Post-Combination Company at any time for cash at a 6% premium under certain conditions specified in the Yorkville Note. Upon repayment of the Yorkville Note, or, if there is an outstanding balance under the Yorkville Note and an amortization event occurs under the Yorkville Note, the Post-Combination Company may cause Yorkville to purchase up to $50,000,000 of the Post-Combination Company’s common stock at a price per share calculated in accordance with the SEPA.

For more information about the SEPA and the Yorkville Note, see the subsection entitled “Yorkville Financing” on page 291.

The following disclosure on page 108 is amended and restated as follows (new text in underline):

…The details of such purchases would be disclosed by ACAB in a Current Report on Form 8-K prior to the Special Meeting, and would be made in compliance with Rule 14e-5 under the Securities Exchange Act of 1934, relying on the Tender Offer Compliance and Disclosure Interpretation 166.01 (March 22, 2022).

The issuance of the Post-Combination Company’s common stock in the Yorkville financing after the completion of the Business Combination could result in substantial dilution, which could materially affect the trading price of the Post-Combination Company’s common stock. 

ACAB and Abpro entered into the SEPA with Yorkville in October 2024. The SEPA grants the Post-Combination Company the right, but not the obligation, to require Yorkville to purchase, from time to time, following the consummation of the Business Combination, up to $50,000,000 of newly issued shares of the Post-Combination Company’s common stock. To the extent the Post-Combination Company exercises its right to sell such shares under the SEPA, the Post-Combination Company will need to issue new shares of the Post-Combination Company’s common stock to Yorkville. Although the Post-Combination Company cannot predict the number of shares of the Post-Combination Company’s common stock that would actually be issued in connection with any such sale, such issuances could result in substantial dilution and decreases to the Post-Combination Company’s stock price. In addition, under the terms of the SEPA, Yorkville will receive from the Post-Combination Company the number of shares of the Post-Combination Company’s common stock that would have a market value of $500,000 based on the average daily VWAP of Post-Combination Company’s common stock on the three trading days prior to the 20th trading day following the Closing. Yorkville will have the right to sell such shares, which it may choose to do at any price, and will be able to retain the proceeds of such sales.

The following disclosure on page 291 is amended and restated as follows (new text in underline):

…On August 22, 2024, ACAB and Celltrion entered into an Investor Rights Agreement (the “IRA”) in connection with the Celltrion Subscription Agreement, which, among other things, provides for the designation by Celltrion of a director nominee at the next annual meeting of the surviving company following the successful consummation of the Business Combination.

Yorkville Financing 

Standby Equity Purchase Agreement 

On October 30, 2024, Abpro, ACAB and Yorkville entered into the SEPA. Upon the closing of the Business Combination, the Post-Combination Company will have the right, provided there is no balance outstanding under any Yorkville Note or, if there is a balance outstanding under a Yorkville Note, with Yorkville’s prior written consent, or upon the occurrence of an Amortization Event (as defined in the Yorkville Note), to issue and sell to Yorkville, and Yorkville shall purchase from the Post-Combination Company, as Advances (as defined in the SEPA) up to $50 million in aggregate gross purchase price of newly issued shares of Post-Combination Company’s common stock by delivering written Advance Notice (as defined in the SEPA) to Yorkville. The purchase price for the Advance Shares (as defined in the SEPA) shall be the price per Advance Share obtained by multiplying the Market Price (as defined in the SEPA) (i) by 96% in respect of an Advance Notice delivered by the Post-Combination Company with an Option 1 Pricing Period (defined by reference to VWAP on the trading day the Advance Notice is submitted, starting at 9:00 a.m. New York City time or, if submitted after 9:00 a.m. New York City time, at the time the investor confirms receipt), (ii) 97% in respect of an Advance Notice with an Option 2 Pricing Period (defined by reference to the lowest daily VWAP on three consecutive trading days commencing on the Advance Notice Date), or (iii) in the case of any Advance Notice delivered pursuant to an Investor Notice (as defined in the SEPA), equal to the Conversion Price (as defined in the Yorkville Note). VWAP means for purposes of the Yorkville financing, for any trading day, the daily volume weighted average price of the Post-Combination Company’s common stock for such trading day on the Nasdaq Stock Market LLC during regular trading hours as reported by Bloomberg L.P. During the commitment period and while any Yorkville Notes are outstanding, Yorkville may also deliver a written Investor Notice to the Post-Combination Company causing an Advance Notice to be deemed delivered to Yorkville.

As consideration for the SEPA, Yorkville will receive from the Post-Combination Company the number of shares of the Post-Combination Company’s common stock that would have a market value of $500,000 based on the average daily VWAP of Post-Combination Company’s common stock on the three trading days prior to the 20th trading day following the Closing. Yorkville shall be entitled to sell such shares at its sole discretion and retain one hundred percent (100%) of the sale proceeds of such shares.

The issuance of the common stock under the SEPA will be subject to certain limitations, including (a) the Ownership Limitation (as defined in the SEPA) that Yorkville may not purchase any common stock that would result in it owning more than 4.99% of the Post-Combination Company’s common stock at any given time and (b) the Exchange Cap (as defined in the SEPA) that the aggregate number of shares of common stock issued pursuant to Pre-Paid Advances and any other Advances cannot exceed 19.99% of the common stock of the Post-Combination Company outstanding as of the effective date of the SEPA. The Exchange Cap shall not be applicable if: (a) the Post-Combination Company’s stockholders have approved the issuance of common stock in excess of the Exchange Cap in accordance with the applicable rules of Nasdaq or (b) the average price of all sales of common stock under the SEPA equals or exceed the lower of (i) the Nasdaq official closing price immediately preceding the effective date of the SEPA; or (ii) the average Nasdaq official closing price for the five trading days immediately preceding the effective date.

Pre-Paid Advance 

In connection with the SEPA, and subject to the conditions set forth therein, including the closing of the Business Combination, Yorkville shall make a Pre-Paid Advance of up to $5 million as evidenced by the Yorkville Notes, which is being issued with an 8% original issue discount. Other than up to $500,000, the proceeds from the funding of the Pre-Paid Advance may not be used by the Post-Combination Company to make any payments in respect of related party transactions. Other than up to $2 million, the proceeds from the funding of the Pre-Paid Advance may not be used to pay transaction expenses related to the Business Combination.

The Yorkville Notes for the Pre-Paid Advance will be due 12 months from the date of issuance of the first Yorkville Note, and interest shall accrue on the outstanding balance of the Yorkville Notes at an annual rate equal to 0%, subject to an increase to 18% upon an event of default as described in the Yorkville Notes. The Yorkville Notes shall be convertible by Yorkville into shares of common stock at the Conversion Price. The Conversion Amount of shares issuable upon conversion of any amount of principal being converted shall be determined by dividing (x) such Conversion Amount (as defined in the Yorkville Notes) by (y) the Conversion Price. The Conversion Price is the lower of (a) the Fixed Price of $11.50 (subject to downward adjustment to the average daily VWAP of Post-Combination Company’s common stock on the three trading days prior to the 20th trading day following a Closing in the event such price is lower than the Floor Price (as defined in the Yorkville Note)), or (b) the Variable Price of 94% of the lowest daily VWAP of the common stock on Nasdaq during the five consecutive trading days immediately prior to each date of conversion, but which Variable Price shall not be lower than the Floor Price then in effect. The Floor Price solely with respect to the Variable Price, means the lower of (i) 20% of the closing price per share on the day of issuance of the applicable Yorkville Note per share or (ii) 20% of the closing price on the trading day prior to the registration statement on Form S-1 (or Forms S-3, if eligible) with the SEC covering the resale of the common stock subject to the SEPA being declared effective by the SEC (as defined below), or as reduced in accordance with the terms of the Yorkville Notes. Notwithstanding the foregoing, the Post-Combination Company may reduce the Floor Price to any amounts set forth in a written notice to Yorkville, provided, that such Floor Price shall not be more than 75% of the Nasdaq closing price on the trading day prior to such reduction and such reduction shall be irrevocable and shall not be subject to increase thereafter.

The Post-Combination Company, at its option, shall have the right, but not the obligation, to undertake an Optional Redemption (as defined in the Yorkville Notes) and redeem early a portion or all amounts outstanding under the Yorkville Notes; provided that (i) the Post-Combination Company provides Yorkville with no less than five (5) trading days’ prior written notice of the redemption notice and (ii) on the date the redemption notice is issued, the VWAP of the Post-Combination Company’s common stock is less than the Fixed Price. Each redemption notice shall be irrevocable and shall specify the outstanding balance of the note to be redeemed and the redemption amount. The redemption amount shall be equal to the outstanding principal balance being redeemed by the Post-Combination Company, plus the Redemption Premium (as defined in the Yorkville Note), plus all accrued and unpaid interest. After receipt of the Redemption Notice, Yorkville shall have five (5) trading days to elect to convert all or any portion of the Yorkville Note. On the sixth (6th) trading day after the Redemption Notice, the Post-Combination Company shall deliver to Yorkville the redemption amount with respect to the principal amount redeemed after giving effect to conversions effected during the five (5) trading day period.

Under the terms of the Yorkville Notes, an Amortization Event shall occur on the Amortization Date (as defined in the Yorkville Notes) if (i) as a Floor Price Event (as defined in the Yorkville Notes), the daily VWAP is less than the Floor Price for five trading days during a period of seven consecutive trading days, (ii) as an Exchange Cap Event (as defined in the Yorkville Notes), if the Post-Combination Company has issued in excess of 99% of the Common Stock available under the Exchange Cap, or (iii) as a Registration Event (as defined in the Yorkville Notes), any time after the Effectiveness Deadline (as defined in the Registration Rights Agreement), Yorkville is unable to utilize a Registration Statement to resell Underlying Shares for a period of ten (10) consecutive Trading Days. If an Amortization Event occurs, then the Post-Combination Company will be obligated to make monthly payments of an amount equal to the sum of (i) the Amortization Principal Amount (as defined in the Yorkville Notes) of $1,250,000 of principal in the aggregate among all Yorkville Notes (or the outstanding principal if less than such amount), plus (ii) a payment premium of 5% in respect of such Amortization Principal Amount, and (iii) accrued and unpaid interest hereunder as of each payment date beginning on the 7th trading day after the Amortization Date and continuing on the same day of each successive calendar month to Yorkville pursuant to the terms of the Yorkville Notes. The obligation of the Post-Combination Company to make monthly prepayments shall cease (with respect to any payment that has not yet come due) if any time after the Amortization Date (a) in the case of a Floor Price Event, the Post-Combination Company reduces the Floor Price to an amount that is permissible under the Yorkville Notes or the daily VWAP is greater than the Floor Price for a period of seven consecutive trading days, (b) in the case of an Exchange Cap Event, the date the Post-Combination Company has obtained stockholder approval to increase the number of shares of common stock under the Exchange Cap and/or the Exchange Cap no longer applies, or (c) in the case of a

Registration Event, the condition or event causing the Registration Event has been cured or Yorkville is able to resell the Company Shares issuable upon conversion of the Yorkville Notes without limitations in accordance with Rule 144 under the Securities Act, unless, in any of the foregoing cases, a subsequent Amortization Event occurs.

Yorkville Registration Rights Agreement 

In connection with the execution of the SEPA, ACAB and Abpro entered into the Yorkville Registration Rights Agreement with Yorkville on October 30, 2024, pursuant to which the Post-Combination Company agrees to file within 30 calendar days of the date of the Closing, a registration statement on Form S-1 (or Forms S-3, if eligible) with the SEC covering the resale of the common stock subject to the SEPA requested to be included in the Resale Registration Statement, and the Post-Combination Company shall use its best efforts to have the Resale Registration Statement declared effective as soon as practicable after the filing thereof, but in no event later than (a) the 60th calendar day following the filing of the Resale Registration Statement or (b), the fifth business day following the date on which the Post-Combination Company is notified by the SEC that the Resale Registration Statement will not be or is no longer subject to further review and comments.

Important Information and Where to Find It

In connection with the Business Combination and the transactions contemplated thereby (the “Proposed Transactions”), ACAB has filed a Registration Statement on Form S-4, as amended, with the Securities and Exchange Commission (the “SEC”), which includes the Proxy Statement distributed to holders of ACAB’s common stock in connection with ACAB’s solicitation of proxies for the vote by ACAB’s stockholders with respect to the Proposed Transactions and other matters as described in the Registration Statement and a prospectus relating to the offer of the securities to be issued to stockholders in connection with the Proposed Transactions. ACAB has mailed a definitive proxy statement/prospectus to its stockholders. Investors and security holders and other interested parties are urged to read the proxy statement/prospectus, any amendments thereto and any other documents filed with the SEC carefully and in their entirety when they become available because they will contain important information about ACAB, Abpro and the Proposed Transactions. When available, investors and security holders may obtain free copies of the definitive proxy statement/prospectus and other documents filed with the SEC by ACAB through the website maintained by the SEC at http://www.sec.gov, or by directing a request to: Atlantic Coastal Acquisition Corp. II, 6 St Johns Lane, Floor 5 New York, NY 10013.

Participants in the Solicitation

ACAB and Abpro and their respective directors and certain of their respective executive officers and other members of management and employees may be considered participants in the solicitation of proxies with respect to the Proposed Transactions. Information about the directors and executive officers of ACAB is set forth in its Annual Report on Form 10-K for the fiscal year ended December 30, 2023 and the Registration Statement. Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, is included in the Registration Statement and other relevant materials filed, or to be filed, with the SEC regarding the Proposed Transactions. Stockholders, potential investors and other interested persons should read the Registration Statement carefully when it becomes available before making any voting or investment decisions. When available, these documents can be obtained free of charge from the sources indicated above.

No Offer or Solicitation

This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act.

Forward-Looking Statements

This Current Report on Form 8-K includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe”, “project”, “expect”, “anticipate”, “estimate”, “intend”, “strategy”, “future”, “opportunity”, “plan”, “may”, “should”, “will”, “would”, “will be”, “will continue”, “will likely result” or similar expressions. that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of revenue and other financial and performance metrics and projections of market opportunity and expectations, ACAB’s ability to enter into definitive agreements or consummate a transaction with Abpro; ACAB’s ability to obtain the financing necessary consummate the Proposed Transactions; and the expected timing of completion of the Proposed Transactions. These statements are based on various assumptions and on the current expectations of ACAB’s and Abpro’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of ACAB and Abpro. These forward looking statements are subject to a number of risks and uncertainties, including general economic, financial, legal, political and business conditions and changes in domestic and foreign markets; the outcome of judicial proceedings to which Abpro is, or may become a party; the inability of the parties to enter into definitive agreements or successfully or timely consummate the Proposed Transactions or to satisfy the other conditions to the closing of the Proposed Transactions, including the risk that any required regulatory approvals are not obtained, are delayed or are subject to unanticipated conditions that could adversely affect the combined company; the risk that the approval of the stockholders of ACAB for the Proposed Transactions is not obtained; failure to realize the anticipated benefits of the Proposed Transactions, including as a result of a delay in consummating the Proposed Transaction or difficulty in, or costs associated with, integrating the businesses of ACAB and Abpro; the amount of redemption requests made by ACAB’s stockholders; the occurrence of events that may give rise to a right of one or both of ACAB and Abpro to terminate the Business Combination Agreement; risks related to the rollout of Abpro’s business and the timing of expected business milestones; the effects of competition on Abpro’s future business; and those factors discussed in ACAB’s Registration Statement on Form S-1 filed with the SEC on January 18, 2022, Annual Report on Form 10-K for the fiscal year ended December 31, 2023, Quarterly Reports on Form 10-Q for the quarters ended March 31, 2024 and June 30, 2024 and the Registration Statement under the heading “Risk Factors,” and other documents of ACAB filed, or to be filed, with the SEC. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that neither ACAB nor Abpro presently know or that ACAB and Abpro currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect ACAB’s and Abpro’s expectations, plans or forecasts of future events and views as of the date of this Current Report on Form 8-K. ACAB and Abpro anticipate that subsequent events and developments will cause their assessments to change. However, while ACAB and Abpro may elect to update these forward-looking statements at some point in the future, ACAB and Abpro specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing ACAB’s or Abpro’s assessments as of any date subsequent to the date of this Current Report on Form 8-K. Accordingly, undue reliance should not be placed upon the forward-looking statements. Neither ACAB nor Abpro gives any assurance that either ACAB or Abpro, or the combined company, will achieve its objectives.

(d) Exhibits

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.